The US Patent and Trademark Office has awarded a specialist pharmaceutical company a patent for a cannabidiol treatment of Fragile X Syndrome – a genetic condition. Other items include news from Australia, Latin America, the EU and the US
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields
Notifications